These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 17634948)

  • 1. A meta-analysis and systematic review of the efficacy and safety of anticoagulants as cancer treatment: impact on survival and bleeding complications.
    Kuderer NM; Khorana AA; Lyman GH; Francis CW
    Cancer; 2007 Sep; 110(5):1149-61. PubMed ID: 17634948
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Meta-analysis on anticoagulation and prevention of thrombosis and mortality among patients with lung cancer.
    Fuentes HE; Oramas DM; Paz LH; Casanegra AI; Mansfield AS; Tafur AJ
    Thromb Res; 2017 Jun; 154():28-34. PubMed ID: 28402864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of low molecular weight heparin, unfractionated heparin and warfarin for thrombo-embolism prophylaxis in orthopaedic surgery: a meta-analysis of randomised clinical trials.
    Palmer AJ; Koppenhagen K; Kirchhof B; Weber U; Bergemann R
    Haemostasis; 1997; 27(2):75-84. PubMed ID: 9212355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Parenteral anticoagulation in patients with cancer who have no therapeutic or prophylactic indication for anticoagulation.
    Akl EA; Gunukula S; Barba M; Yosuico VE; van Doormaal FF; Kuipers S; Middeldorp S; Dickinson HO; Bryant A; Schünemann H
    Cochrane Database Syst Rev; 2011 Jan; (1):CD006652. PubMed ID: 21249680
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The efficacy and safety of low-molecular-weight heparin use for cancer treatment: a meta-analysis.
    Che DH; Cao JY; Shang LH; Man YC; Yu Y
    Eur J Intern Med; 2013 Jul; 24(5):433-9. PubMed ID: 23385011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral anticoagulation for prolonging survival in patients with cancer.
    Akl EA; Kamath G; Kim SY; Yosuico V; Barba M; Terrenato I; Sperati F; Schünemann HJ
    Cochrane Database Syst Rev; 2007 Apr; (2):CD006466. PubMed ID: 17443622
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative effectiveness of low-molecular-weight heparins versus other anticoagulants in major orthopedic surgery: a systematic review and meta-analysis.
    Sobieraj DM; Coleman CI; Tongbram V; Chen W; Colby J; Lee S; Kluger J; Makanji S; Ashaye A; White CM
    Pharmacotherapy; 2012 Sep; 32(9):799-808. PubMed ID: 22744711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Parenteral anticoagulation in patients with cancer who have no therapeutic or prophylactic indication for anticoagulation.
    Akl EA; Gunukula S; Barba M; Yosuico VE; van Doormaal FF; Kuipers S; Middeldorp S; Dickinson HO; Bryant A; Schünemann H
    Cochrane Database Syst Rev; 2011 Apr; (4):CD006652. PubMed ID: 21491396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Parenteral anticoagulation for prolonging survival in patients with cancer who have no other indication for anticoagulation.
    Akl EA; van Doormaal FF; Barba M; Kamath G; Kim SY; Kuipers S; Middeldorp S; Yosuico V; Dickinson HO; Schünemann HJ
    Cochrane Database Syst Rev; 2007 Jul; (3):CD006652. PubMed ID: 17636846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral anticoagulation in patients with cancer who have no therapeutic or prophylactic indication for anticoagulation.
    Akl EA; Vasireddi SR; Gunukula S; Yosuico VE; Barba M; Terrenato I; Sperati F; Schünemann H
    Cochrane Database Syst Rev; 2010 Dec; (12):CD006466. PubMed ID: 21154368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deep venous thrombosis and pulmonary embolism. Part 2--Prevention of recurrences: warfarin or low-molecular-weight heparin for at least 3 months.
    Prescrire Int; 2013 May; 22(138):129-33. PubMed ID: 23819181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral anticoagulation in patients with cancer who have no therapeutic or prophylactic indication for anticoagulation.
    Akl EA; Vasireddi SR; Gunukula S; Yosuico VE; Barba M; Terrenato I; Sperati F; Schünemann H
    Cochrane Database Syst Rev; 2011 Jun; (6):CD006466. PubMed ID: 21678357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-molecular-weight-heparins as periprocedural anticoagulation for patients on long-term warfarin therapy: a standardized bridging therapy protocol.
    Jaffer AK; Ahmed M; Brotman DJ; Bragg L; Seshadri N; Qadeer MA; Klein A
    J Thromb Thrombolysis; 2005 Aug; 20(1):11-6. PubMed ID: 16133889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tinzaparin vs Warfarin for Treatment of Acute Venous Thromboembolism in Patients With Active Cancer: A Randomized Clinical Trial.
    Lee AYY; Kamphuisen PW; Meyer G; Bauersachs R; Janas MS; Jarner MF; Khorana AA;
    JAMA; 2015 Aug; 314(7):677-686. PubMed ID: 26284719
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Complications and risks associated with an anticoagulation therapy combining low molecular weight heparin and Warfarin after total replacement of large joints--our experience].
    Míka P; Behounek J; Skoták M; Nevsímal L
    Acta Chir Orthop Traumatol Cech; 2004; 71(4):237-44. PubMed ID: 15456102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low-molecular-weight heparin in cancer-associated thrombosis: treatment, secondary prevention, and survival.
    Nishioka J; Goodin S
    J Oncol Pharm Pract; 2007 Jun; 13(2):85-97. PubMed ID: 17873108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral direct Factor Xa inhibitors versus low-molecular-weight heparin to prevent venous thromboembolism in patients undergoing total hip or knee replacement: a systematic review and meta-analysis.
    Neumann I; Rada G; Claro JC; Carrasco-Labra A; Thorlund K; Akl EA; Bates SM; Guyatt GH
    Ann Intern Med; 2012 May; 156(10):710-9. PubMed ID: 22412038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and efficacy of low molecular weight heparins in children: a systematic review of the literature and meta-analysis of single-arm studies.
    Bidlingmaier C; Kenet G; Kurnik K; Mathew P; Manner D; Mitchell L; Krümpel A; Nowak-Göttl U
    Semin Thromb Hemost; 2011 Oct; 37(7):814-25. PubMed ID: 22187405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thromboprophylaxis in cancer patients with central venous catheters. A systematic review and meta-analysis.
    Chaukiyal P; Nautiyal A; Radhakrishnan S; Singh S; Navaneethan SD
    Thromb Haemost; 2008 Jan; 99(1):38-43. PubMed ID: 18217132
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treating patients with venous thromboembolism: initial strategies and long-term secondary prevention.
    Huisman MV; Bounameaux H
    Semin Vasc Med; 2005 Aug; 5(3):276-84. PubMed ID: 16123915
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.